These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 2395495

  • 41. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
    Raal FJ, Santos RD, Blom DJ, Marais AD, Charng MJ, Cromwell WC, Lachmann RH, Gaudet D, Tan JL, Chasan-Taber S, Tribble DL, Flaim JD, Crooke ST.
    Lancet; 2010 Mar 20; 375(9719):998-1006. PubMed ID: 20227758
    [Abstract] [Full Text] [Related]

  • 42. [LDL apheresis in the treatment of hyperlipoproteinemia].
    Ishikawa K.
    Nihon Rinsho; 1994 Dec 20; 52(12):3298-302. PubMed ID: 7853726
    [Abstract] [Full Text] [Related]

  • 43. Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia.
    Fadul JE, Sandhagen B, Linde T, Vessby B, Wikström B, Danielson BG.
    Blood Purif; 1997 Dec 20; 15(3):182-7. PubMed ID: 9262844
    [Abstract] [Full Text] [Related]

  • 44. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
    Kauppinen-Mäkelin R, Koivisto V, Virtanen KS, Taskinen MR, Miettinen T.
    Duodecim; 1990 Dec 20; 106(21):1465-70. PubMed ID: 1364677
    [No Abstract] [Full Text] [Related]

  • 45. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
    Tsuchida M, Kawashiri MA, Tada H, Takata M, Nohara A, Ino H, Inazu A, Kobayashi J, Koizumi J, Mabuchi H, Yamagishi M.
    Circ J; 2009 May 20; 73(5):963-6. PubMed ID: 19088396
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO, Donner MG, Höfling B, Schwandt P.
    Metabolism; 1998 Jul 20; 47(7):863-8. PubMed ID: 9667236
    [Abstract] [Full Text] [Related]

  • 50. Changes in lipoprotein(a), LDL-cholesterol and apolipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL-apheresis.
    Lasunción MA, Teruel JL, Alvarez JJ, Carrero P, Ortuño J, Gómez-Coronado D.
    Eur J Clin Invest; 1993 Dec 20; 23(12):819-26. PubMed ID: 8143758
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.
    Page MM, Ekinci EI, Jones RM, Angus PW, Gow PJ, O'Brien RC.
    Intern Med J; 2014 Jun 20; 44(6):601-4. PubMed ID: 24946816
    [Abstract] [Full Text] [Related]

  • 53. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia.
    Kolovou G, Diakoumakou O, Kolovou V, Fountas E, Stratakis S, Zacharis E, Liberopoulos EN, Matsouka F, Tsoutsinos A, Mastorakou I, Katsikas T, Mavrogeni S, Hatzigeorgiou G.
    Eur J Prev Cardiol; 2020 Jan 20; 27(2):157-165. PubMed ID: 31403880
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.
    Napoli C, Ambrosio G, Scarpato N, Corso G, Palumbo G, D'Armiento FP, Mancini FP, Malorni A, Formisano S, Ruocco A, Calí A, Chiariello M.
    Am Heart J; 1997 May 20; 133(5):585-95. PubMed ID: 9141382
    [Abstract] [Full Text] [Related]

  • 58. [Low density lipoprotein apheresis].
    Zaliūnas R, Slapikas R, Gustiene O, Siurkus J, Vaitkus E.
    Medicina (Kaunas); 2003 May 20; 39(12):1158-64. PubMed ID: 14704503
    [Abstract] [Full Text] [Related]

  • 59. [LDL apheresis].
    Nakamura T.
    Nihon Rinsho; 2001 Mar 20; 59 Suppl 3():707-14. PubMed ID: 11347159
    [No Abstract] [Full Text] [Related]

  • 60. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.
    Schmidt HH, Stuhrmann M, Shamburek R, Schewe CK, Ebhardt M, Zech LA, Büttner C, Wendt M, Beisiegel U, Brewer HB, Manns MP.
    J Clin Endocrinol Metab; 1998 Jun 20; 83(6):2167-74. PubMed ID: 9626156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.